Logo image of AAC

ARES ACQUISITION CORP-A (AAC) Stock Fundamental Analysis

NYSE:AAC - New York Stock Exchange, Inc. - KYG330321061 - Common Stock - Currency: USD

10.79  +0.02 (+0.19%)

Fundamental Rating

1

Overall AAC gets a fundamental rating of 1 out of 10. We evaluated AAC against 0 industry peers in the Unkown industry. AAC has a bad profitability rating. Also its financial health evaluation is rather negative. AAC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AAC has reported negative net income.
In the past year AAC has reported a negative cash flow from operations.
AAC Yearly Net Income VS EBIT VS OCF VS FCFAAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2020 2021 2022 0 20M -20M -40M -60M

1.2 Ratios

Industry RankSector Rank
ROA -1.32%
ROE -1.59%
ROIC N/A
ROA(3y)0.34%
ROA(5y)N/A
ROE(3y)-40.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AAC Yearly ROA, ROE, ROICAAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2020 2021 2022 0 -20 -40 -60 -80 -100

1.3 Margins

AAC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AAC Yearly Profit, Operating, Gross MarginsAAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2020 2021 2022 0 -10 -20

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for AAC remains at a similar level compared to 1 year ago.
The debt/assets ratio for AAC is higher compared to a year ago.
AAC Yearly Shares OutstandingAAC Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2020 2021 2022 20M 40M 60M 80M 100M
AAC Yearly Total Debt VS Total AssetsAAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 5.22 indicates that AAC is not in any danger for bankruptcy at the moment.
AAC has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 5.22
ROIC/WACCN/A
WACCN/A
AAC Yearly LT Debt VS Equity VS FCFAAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2020 2021 2022 0 200M 400M 600M 800M

2.3 Liquidity

AAC has a Current Ratio of 0.01. This is a bad value and indicates that AAC is not financially healthy enough and could expect problems in meeting its short term obligations.
AAC has a Quick Ratio of 0.01. This is a bad value and indicates that AAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
AAC Yearly Current Assets VS Current LiabilitesAAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2020 2021 2022 100M 200M 300M

More info and screens

0

3. Growth

3.1 Past

AAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -173.41%.
EPS 1Y (TTM)-173.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-176.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AAC Yearly Revenue VS EstimatesAAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 100M 200M 300M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AAC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAC Price Earnings VS Forward Price EarningsAAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAC Per share dataAAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARES ACQUISITION CORP-A

NYSE:AAC (11/6/2023, 8:04:00 PM)

10.79

+0.02 (+0.19%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-14 2023-11-14
Earnings (Next)02-27 2024-02-27
Inst Owners5.09%
Inst Owner Change0%
Ins Owners14.47%
Ins Owner Change0%
Market Cap761.77M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.89
P/tB 1.89
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS5.71
TBVpS5.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.32%
ROE -1.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)0.34%
ROA(5y)N/A
ROE(3y)-40.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 5.22
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-173.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-176.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-139.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-56.45%
OCF growth 3YN/A
OCF growth 5YN/A